Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging.

MLA

Vyas, Rahul, et al. “Evaluating the Efficacy and Safety of Mavacamten in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis Focusing on Qualitative Assessment, Biomarkers, and Cardiac Imaging.” PLoS ONE, vol. 19, no. 4, Apr. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0301704.

APA

Vyas, R., Panchal, V., Jain, S., Sondhi, M., Singh, M., Jaisingh, K., Thotamgari, S. R., Thakre, A., & Modi, K. (2024). Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging. PLoS ONE, 19(4), 1–14. https://doi.org/10.1371/journal.pone.0301704

Chicago

Vyas, Rahul, Viraj Panchal, Shubhika Jain, Manush Sondhi, Mansunderbir Singh, Keerthish Jaisingh, Sahith Reddy Thotamgari, Anuj Thakre, and Kalgi Modi. 2024. “Evaluating the Efficacy and Safety of Mavacamten in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis Focusing on Qualitative Assessment, Biomarkers, and Cardiac Imaging.” PLoS ONE 19 (4): 1–14. doi:10.1371/journal.pone.0301704.